It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Cardiac arrest (CA) is a leading cause of death and there is a necessity for animal models that accurately represent human injury severity. We evaluated a rat model of severe CA injury by comparing plasma metabolic alterations to human patients. Plasma was obtained from adult human control and CA patients post-resuscitation, and from male Sprague–Dawley rats at baseline and after 20 min CA followed by 30 min cardiopulmonary bypass resuscitation. An untargeted metabolomics evaluation using UPLC-QTOF-MS/MS was performed for plasma metabolome comparison. Here we show the metabolic commonality between humans and our severe injury rat model, highlighting significant metabolic dysfunction as seen by similar alterations in (1) TCA cycle metabolites, (2) tryptophan and kynurenic acid metabolites, and (3) acylcarnitine, fatty acid, and phospholipid metabolites. With substantial interspecies metabolic similarity in post-resuscitation plasma, our long duration CA rat model metabolically replicates human disease and is a suitable model for translational CA research.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Feinstein Institutes for Medical Research, Laboratory for Critical Care Physiology, Manhasset, USA; Donald and Barbara Zucker School of Medicine At Hofstra/Northwell, Hempstead, USA (GRID:grid.257060.6) (ISNI:0000 0001 2284 9943)
2 Feinstein Institutes for Medical Research, Laboratory for Critical Care Physiology, Manhasset, USA (GRID:grid.257060.6)
3 Oregon State University, Linus Pauling Institute, Corvallis, USA (GRID:grid.4391.f) (ISNI:0000 0001 2112 1969); Oregon State University, Department of Pharmaceutical Sciences, Corvallis, USA (GRID:grid.4391.f) (ISNI:0000 0001 2112 1969)
4 Donald and Barbara Zucker School of Medicine At Hofstra/Northwell, Hempstead, USA (GRID:grid.257060.6) (ISNI:0000 0001 2284 9943)
5 Feinstein Institutes for Medical Research, Laboratory for Critical Care Physiology, Manhasset, USA (GRID:grid.4391.f); Donald and Barbara Zucker School of Medicine At Hofstra/Northwell, Hempstead, USA (GRID:grid.257060.6) (ISNI:0000 0001 2284 9943); Department of Emergency Medicine, Northwell Health, USA (GRID:grid.416477.7) (ISNI:0000 0001 2168 3646)
6 Feinstein Institutes for Medical Research, Laboratory for Critical Care Physiology, Manhasset, USA (GRID:grid.416477.7); Donald and Barbara Zucker School of Medicine At Hofstra/Northwell, Hempstead, USA (GRID:grid.257060.6) (ISNI:0000 0001 2284 9943); Department of Emergency Medicine, Northwell Health, USA (GRID:grid.416477.7) (ISNI:0000 0001 2168 3646)